皮肤状甲状腺微癌的风险名谱,其中包括中央淋巴结转移和术后甲状腺功能随访
Yuting Huang1, Pengwei Lou2, Hui Li3
1Department of Medical Administration, Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University, Urumqi, China.
Frontiers in endocrinology
|November 12, 2024
概括
这项研究开发了一种名谱,用于预测皮皮性甲状腺微癌 (PTMC) 患者的中枢淋巴结转移 (CLNM). 该模型准确地识别了风险因素,有助于对PTMC治疗的临床决策.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 手术瘤学手术瘤学
背景情况:
- 皮囊性甲状腺微癌 (PTMC) 的治疗仍然存在争议.
- 准确的手术前识别中央淋巴结转移 (CLNM) 对于PTMC管理至关重要.
- 在PTMC中,CLNM是复发和生存的关键预测因子.
研究的目的:
- 开发和验证用于预测PTMC患者中CLNM发生概率的诺姆图.
- 确定与PTMC中CLNM相关的重大风险因素.
- 为优化PTMC手术方案提供一个工具.
主要方法:
- 对3023名PTMC患者的回顾性分析,分为培训 (n=2116) 和验证 (n=907) 组.
- 利用LASSO和多变量逻辑回归来确定CLNM的风险因素.
- 构建并内部验证了一个名图,在一组患者中对甲状腺功能进行了为期4年的随访.
主要成果:
- 关键的CLNM预测因素包括年轻的年龄,较低的BMI,男性性别,较低的极点位置,化,瘤大小 (0.5-1厘米),多焦点性,ETE,ECLN,LLNM和CEA升高.
- 诺米克获得了0.73 (培训) 和0.75 (验证) 的AUC.
- 手术后甲状腺功能 (FT3,FT4) 在3个月后稳定,在CLNM (+) 组更高,甲状腺功能低下在3个月内更为普遍.
结论:
- 开发的名图表显示了PTMC中CLNM的良好预测性能.
- 该工具为PTMC管理中的临床决策和手术规划提供了有价值的参考.
- 这些发现支持了名图的有用性,用于指导PTMC患者的干预策略.
更多相关视频
04:01Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
Published on: September 15, 2023
725
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
221
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
